Complete Genomics (NASDAQ: GNOM) will present at the BioCentury Future Leaders in the Biotech Industry Conference on Friday, April 15, 2011.
>> read moreComplete Genomics Inc. (NASDAQ: GNOM), a complete human genome sequencing company that has developed and commercialized an innovative DNA sequencing platform, announced today that it has added 29 high-coverage, complete human genome sequences to its public genomic repository.
>> read moreMOUNTAIN VIEW, Calif., and PALO ALTO, Calif. — Complete Genomics Inc. (NASDAQ: GNOM) announced today that its customers can now choose to store and visualize their human genome sequencing data within the cloud-based DNAnexus platform.
>> read moreComplete Genomics (Nasdaq:GNOM) will present at the Barclays Capital Global Healthcare Conference on Thursday, March 17, 2011.
>> read moreComplete Genomics, Inc. (Nasdaq:GNOM) today announced its financial results for the quarter and fiscal year ended December 31, 2010.
>> read moreComplete Genomics, Inc. (Nasdaq:GNOM) will announce its fourth-quarter and fiscal year 2010 financial results following the close of market on Thursday, March 10, 2011.
>> read moreComplete Genomics (NASDAQ: GNOM) will present at the Cowen and Company 31st Annual Health Care Conference on Tuesday, March 8, 2011.
>> read moreComplete Genomics Inc. (NASDAQ: GNOM) announced today that it has been selected by MIT’s Technology Review to be included in the 2011 TR50, its annual list of the 50 most innovative companies in the world.
>> read moreComplete Genomics Inc. (NASDAQ: GNOM), a complete human genome sequencing company that has developed and commercialized an innovative DNA sequencing platform, announced today that it is providing the research community with access to 60 complete, high-coverage human genome sequences.
>> read moreThe Institute for Systems Biology (ISB) and Complete Genomics Inc. (NASDAQ: GNOM) announced today the signing of an agreement that calls for Complete Genomics to sequence 615 complete human genome samples as part of an ISB study on neurodegenerative diseases.
>> read moreMOUNTAIN VIEW, Calif. – Jan. 6, 2011 – Complete Genomics Inc. (NASDAQ: GNOM) announced today that it is providing access to its complete genome sequence data for a family trio from the NHGRI Sample Repository for Human Genetic Research.
>> read moreMOUNTAIN VIEW, Calif. – Jan. 5, 2011 (GLOBE NEWSWIRE) – Complete Genomics (Nasdaq:GNOM) announced today that the Company will present at the upcoming J.P. Morgan Healthcare Conference in San Francisco on January 13, 2011. The presentation is scheduled to begin at 11:30 a.m. Pacific Standard Time and will a feature an overview of the company by...
>> read moreMOUNTAIN VIEW, Calif. – December 17, 2010 – Complete Genomics, Inc. (Nasdaq: GNOM) today announced its unaudited financial results for the quarter ended September 30, 2010. These results were previously summarized in the prospectus relating to the Company’s initial public offering, which closed on November 16, 2010. Revenue in the third quarter ...
>> read moreMOUNTAIN VIEW, Calif. – Dec. 9, 2010 – Complete Genomics Inc. (NASDAQ: GNOM) announced today that its customers will now receive copy number variation (CNV) and structural variation (SV) results as part of the CGA™ Service. This new enhancement includes additional types of variation data including quantitative, large-scale copy number...
>> read moreMOUNTAIN VIEW, Calif. – Nov. 11, 2010 – Complete Genomics, Inc. (NASDAQ: GNOM) announced the pricing of its initial public offering of 6,000,000 shares of its common stock at $9.00 per share. Complete Genomics has granted the underwriters a 30-day option to purchase up to 900,000 additional shares at the initial public offering price, less the...
>> read moreMOUNTAIN VIEW, Calif. — Oct. 5, 2010 — Complete Genomics Inc., a life sciences company focused on human genome sequencing, today announced that it has expanded its suite of Complete Genomics Analysis Tools (CGA™ Tools) to enable customers to more quickly and easily interpret the genomic data it delivers to them. CGA Tools is open source software ...
>> read moreMOUNTAIN VIEW, Calif. – Sept. 7, 2010 – Complete Genomics Inc., a life sciences company focused on human genome sequencing, today announced a collaboration to identify and validate somatic mutations from 50 pediatric cancer cases from multiple research centers across the United States. SAIC-Frederick, on behalf of the National Cancer Institute...
>> read moreMOUNTAIN VIEW, Calif. – March 23, 2010 – Complete Genomics Inc., a third-generation human genome sequencing company, today announced the expansion of its commercial team with the addition of Mark J. Sutherland as senior vice president of business development. Sutherland will be responsible for managing the company’s business development,...
>> read moreMOUNTAIN VIEW, Calif. – March 10, 2010 – Complete Genomics Inc., a third-generation human genome sequencing company, today announced that the Institute for Systems Biology (ISB) employed Complete Genomics’ human genome sequencing service to sequence a family quartet to determine the depth of genetic information possible in analyzing a full...
>> read moreMOUNTAIN VIEW, Calif. – Feb. 25, 2010 – Complete Genomics Inc., a third-generation human genome sequencing company, today announced that it has been included in MIT Technology Review’s TR50, the publication’s 2010 list of the 50 most innovative companies in the world. “The TR50 list is our selection of companies that show the most impressive...
>> read moreCompany continues to expand its capacity rapidly, having already sequenced 50 human genomes in 2009 MOUNTAIN VIEW, Calif. — Feb. 22, 2010 — Complete Genomics Inc., a third-generation human genome sequencing company, today reported on its commercial success. Complete Genomics now has more than 30 customers and a strong pipeline with booked...
>> read moreMOUNTAIN VIEW, Calif. – Jan. 22, 2010 – Complete Genomics Inc., a third-generation human genome sequencing company, today announced that it has been selected as a 2009 Red Herring Global 100 award winner. The company was also recognized as a 2009 Red Herring North America 100 award winner earlier last year. The Red Herring editorial judges...
>> read moreMOUNTAIN VIEW, Calif. — Dec. 8, 2009 — Complete Genomics Inc., a third generation human genome sequencing company, today announced that it has won the Silicon Valley/San Jose Business Journal’s 2009 Biotechnology Emerging Technology Award. Complete Genomics’ Vice President of Marketing Jennifer Turcotte accepted the award on the company’s...
>> read moreMOUNTAIN VIEW, Calif. — Nov. 5, 2009 — Complete Genomics, a third-generation human genome sequencing company, today announced publication of a report in the journal Science describing its proprietary DNA sequencing platform, including analysis of sequence data from three complete human genomes. The consumables cost for these three genomes...
>> read moreProject to sequence an unprecedented 100 human genomes in just six months SEATTLE, Wash., and MOUNTAIN VIEW, Calif. — Nov 2, 2009 — The Institute for Systems Biology (ISB) and Complete Genomics Inc. announced today that they are embarking on a large-scale human genome sequencing study of Huntington’s disease (HD). ISB has engaged Complete...
>> read moreIts high quality, low cost human genome sequencing technology is helping to further cancer, metabolic and neurologic disease research MOUNTAIN VIEW, Calif. — Sept. 9, 2009 — Complete Genomics Inc., a third-generation human genome sequencing company, announced today that it has sequenced, analyzed and delivered 14 human genomes to customers...
>> read moreMOUNTAIN VIEW, Calif. – May 26, 2009 – Complete Genomics, Inc., a third-generation human genome sequencing company, today announced that it has been selected as a 2009 Red Herring 100 North America award winner. The Red Herring editorial team evaluates nominees based on both quantitative and qualitative criteria, such as financial performance,...
>> read moreMOUNTAIN VIEW, Calif. — March 3, 2009 — Complete Genomics Inc., a recently launched, third-generation human genome sequencing company, today announced a collaboration with the Broad Institute of MIT and Harvard to conduct complete human genome sequencing pilot studies of two cancers — glioblastoma and melanoma. Complete Genomics will use its...
>> read moreData corroborate the company’s promise to deliver high-quality, high-throughput commercial human DNA sequencing at a low cost MOUNTAIN VIEW, Calif. — Feb. 6, 2009 — Complete Genomics, Inc. released proof-of-concept (PoC) data for its human genome sequencing technology for the first time yesterday evening. The analysis results were reviewed by...
>> read moreMOUNTAIN VIEW, Calif. — Oct. 22, 2008 — Complete Genomics Inc., a newly launched, third-generation human genome sequencing company, today announced the company’s presentation at the 7th Annual BIO Investor Forum, which will be held in San Francisco, Oct.29–31, 2008. Dr. Clifford Reid, chairman, president and chief executive officer of Complete...
>> read moreMOUNTAIN VIEW, CA and SEATTLE, WA— Oct. 6, 2008 — Complete Genomics, Inc., a newly-launched, third-generation human genome sequencing company, and the Institute for Systems Biology (ISB) today announced their partnership to conduct population-wide human genome studies. In phase one of the project, Complete Genomics will use its proprietary DNA...
>> read moreCompany to sequence 1,000 human genomes in 2009 for $5,000 each MOUNTAIN VIEW, CALIF. — Oct. 6, 2008 — Complete Genomics, Inc., a third-generation human genome sequencing company, today announced its formal launch as the world's first provider of large-scale human genome sequencing services. The company, which was established in March 2006,...
>> read more